Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schönlein nephritis in children
暂无分享,去创建一个
Y. Shin | J. Shin | H. Jeong | J. S. Lee | J. M. Park
[1] Y. Kawasaki,et al. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] J. Bergstein. Glomerular fibrin deposition and removal , 2004, Pediatric Nephrology.
[3] M. Nuutinen,et al. Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis , 2003, Pediatric Nephrology.
[4] P. Carmeliet,et al. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. , 2003, Journal of the American Society of Nephrology : JASN.
[5] Y. Kawasaki,et al. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. , 2003, Pediatrics.
[6] D. Witte,et al. Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. , 2001, American journal of physiology. Renal physiology.
[7] I. T. Ten Berge,et al. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? , 2001, Kidney international.
[8] C. Bernard,et al. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. , 2000, The Journal of pediatrics.
[9] H. Tanaka,et al. Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy. , 1998, The Tohoku journal of experimental medicine.
[10] P. Niaudet,et al. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis , 1998, Pediatric Nephrology.
[11] Shori Takahashi,et al. Pathological improvement of IgA nephropathy and Henoch‐Schönlein purpura nephritis with urokinase therapy , 1996, Acta paediatrica Japonica : Overseas edition.
[12] S. Sasayama,et al. Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schönlein purpura nephritis. , 1996, Nephron.
[13] R. White,et al. Long-term follow-up of childhood Henoch-Schönlein nephritis , 1992, The Lancet.
[14] M. Endoh,et al. Long-term effect of urokinase therapy in IgA nephropathy. , 1989, Clinical nephrology.
[15] P. Tipping,et al. PARTICIPATION OF CELL-MEDIATED IMMUNITY IN DEPOSITION OF FIBRIN IN GLOMERULONEPHRITIS , 1988, The Lancet.
[16] K. Matsumoto,et al. Glomerular deposition of cross-linked fibrin in human kidney diseases. , 1987, Kidney international.
[17] P. Tipping,et al. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. , 1986, British journal of experimental pathology.
[18] M. Endoh,et al. Immunofluorescent studies on alpha 2-plasmin inhibitor (alpha 2-PI) in glomeruli from patients with IgA nephropathy. , 1985, Clinical and experimental immunology.
[19] P. Tipping,et al. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. , 1985, The Journal of clinical investigation.
[20] A. Morley,et al. Cell proliferation within Bowman's capsule in mice , 1985, The Journal of pathology.
[21] C. Chantler,et al. Prognosis of Henoch-Schönlein nephritis in children. , 1977, British medical journal.
[22] S. R. Meadow,et al. Schönlein-Henoch nephritis. , 1972, The Quarterly journal of medicine.
[23] D. Evans,et al. The effect of defibrination on nephrotoxic serum nephritis in rabbits. , 1972, Clinical science.